All Stocks
healthcare

ABT — Abbott Laboratories

Conviction78
Congress 90d5
Insider 90d0
Markets6
Lobbying9
Contracts1
CountryUS

ABT

Abbott Laboratories

healthcare
78thin · 2 src Bullish2 sources agree
🏛 Congress📋 Lobbying

Congressional trades

Last 90 days
4 buy1 sell5 legislators
  • sell Josh Gottheimer$1K–$15K · May 27, 2026
  • buy Gilbert Cisneros$1K–$15K · May 15, 2026
  • buy Julie Johnson$1K–$15K · May 12, 2026
  • buy Richard W. Allen · Apr 16, 2026
  • buy Laura Friedman(Democrat)$1K–$15K · Mar 24, 2026

Prediction markets

Live odds

Lobbying filings

Last 2 years
  • FEDERAL HEALTH POLICY STRATEGIES · 2026 first_quarter
  • TIBER CREEK GROUP$50K · 2026 first_quarter
    BUDFOR
  • LIBERTY PARTNERS GROUP, LLC · 2026 first_quarter
    MMM
  • LIBERTY PARTNERS GROUP, LLC · 2026 first_quarter
    HCRMMM
  • S-3 GROUP$60K · 2026 first_quarter
    AGRHCRMMMTAX
  • MARSHALL & POPP, LLC$60K · 2026 first_quarter
    AGRMMM
  • THE RUSSELL GROUP, INC.$60K · 2026 first_quarter
    AGR
  • KOUNTOUPES DENHAM CARR & REID, LLC$60K · 2026 first_quarter
    FOOHCRTAX
  • MCDERMOTT+ LLC · 2026 first_quarter

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇺🇸 United States78/100
Posture: riskView United States

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

$65.5M · 0% defense
  • Department of Health and Human Services$65.5M · Sep 21, 2022
6c0062c